The effect of a pictogram-guided antihypertensive drug leaflet on patients* recall and understanding of information, self-efficacy, adherence and blood pressure control.

The effect of a pictogram-guided antihypertensive drug leaflet on patients* recall and understanding of information, self-efficacy, adherence and blood pressure control. - Understandable drug information/UDI

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON42631

Enrollment

180

Registered

2015-09-03

Start date

2015-11-18

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

communicatie patient communication/education

Interventions

The control group will receive a standard care, text-only drug information leaflet with their medication. The test group will receive the leaflet enriched with pictograms.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: to get an antihypertensive prescribed for the first time and to not have used an antihypertensive the year before.

Exclusion criteria

Exclusion criteria: - unable to verbally communicate in Dutch - blind

Design outcomes

Primary

Measure	Time frame
The main study parameter is change in blood pressure control between baseline and the first standard control measurement (usually three weeks after start of medication) compared between the control and intervention group.	—

Secondary

Measure	Time frame
Other measures are differences in overall understanding of the information provided in the leaflet, satisfaction with the information, self-efficacy, and (intention to) adherence between the control and intervention group.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)